PRGO FY 2017 Earnings — Perrigo Company plc Revenue & Financial Results | Market Cap Arena

PRGOPerrigo Company plc

$1B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.9B-6.3% YoY

Gross Profit

$2.0B40.0% margin

Operating Income

$598M12.1% margin

Net Income

$120M2.4% margin

EPS (Diluted)

$0.84

Cash Flow

Operating Cash Flow

$699M

Free Cash Flow

$610M

Stock-Based Comp.

$44M

Balance Sheet

Total Assets

$11.6B

Total Liabilities

$5.5B

Stockholders' Equity

$6.2B

Cash & Equivalents

$679M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.9B	$5.3B	-6.3%
Gross Profit	$2.0B	$2.1B	-3.5%
Operating Income	$598M	-$2.0B	+129.9%
Net Income	$120M	-$4.0B	+103.0%